Donor Advised Charitable Giving’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,520
Closed -$371K 54
2021
Q2
$371K Hold
1,520
0.04% 100
2021
Q1
$378K Hold
1,520
0.04% 97
2020
Q4
$349K Sell
1,520
-5
-0.3% -$1.15K 0.05% 97
2020
Q3
$388K Hold
1,525
0.11% 35
2020
Q2
$360K Sell
1,525
-260
-15% -$59.3K 0.14% 31
2020
Q1
$362K Buy
1,785
+285
+19% +$62.3K 0.18% 24
2019
Q4
$362K Buy
1,500
+305
+26% +$67.2K 0.2% 34
2019
Q3
$231K Buy
1,195
+95
+9% +$18.2K 0.18% 49
2019
Q2
$203K Buy
+1,100
New +$197K 0.16% 53

Other funds holding AMGN

Donor Advised Charitable Giving's AMGN Position: Q3 2021 in Review

Donor Advised Charitable Giving sold out of Amgen (AMGN) in Q3 2021, closing a stake of 1,520 shares — an estimated $371K sold.

Donor Advised Charitable Giving first reported a position in AMGN in Q2 2019 and held it in 9 quarters. The position peaked at $388K in Q3 2020. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Donor Advised Charitable Giving reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • Donor Advised Charitable Giving sold 1,520 Amgen shares in Q3 2021, an estimated $371K.
  • Donor Advised Charitable Giving first reported a position in Amgen in Q2 2019 and held it in 9 quarters.
  • Donor Advised Charitable Giving's Amgen position peaked at $388K in Q3 2020.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Donor Advised Charitable Giving's 13F filing for Q3 2021, filed 14 Oct 2021.